Scientific article
Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study
ContributorsOrasch, Christina; Mertz, Dominik; Garbino, Jorge; Van Delden, Christian; Emonet, Stéphane; Schrenzel, Jacques; Zimmerli, Stefan; Damonti, Lauro; Mühlethaler, Konrad; Imhof, Alexander; Ruef, Christian; Fehr, Jan; Zbinden, Reinhard; Boggian, Katia; Bruderer, Thomas; Flückiger, Ursula; Conen, Anna; Khanna, Nina; Frei, Reno; Bregenzer, Thomas; Lamoth, Frédéric; Erard, Véronique; Bochud, Pierre-Yves; Calandra, Thierry; Bille, Jacques; Marchetti, Oscar; Fungal Infection Network of Switzerland (FUNGINOS)
Published inJournal of Infection, vol. 76, no. 5, p. 489-495
Publication date2018
Abstract
Keywords
- Adolescent
- Adult
- Aged
- 80 and over
- Antifungal Agents/administration & dosage
- Candida/drug effects
- Candidemia/microbiology/mortality/prevention & control
- Child
- Preschool
- Drug Resistance
- Fungal
- Epidemiological Monitoring
- Female
- Fluconazole/administration & dosage
- Humans
- Infant
- Newborn
- Male
- Microbial Sensitivity Tests
- Middle Aged
- Prospective Studies
- Young Adult
Affiliation entities
Citation (ISO format)
ORASCH, Christina et al. Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study. In: Journal of Infection, 2018, vol. 76, n° 5, p. 489–495. doi: 10.1016/j.jinf.2017.12.018
Main files (1)
Article (Published version)
Identifiers
- PID : unige:127252
- DOI : 10.1016/j.jinf.2017.12.018
- PMID : 29378240
Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S016344531830029X
Journal ISSN0163-4453
